Showing results (211-220 of 295) with videos related to
Sort By:
Pageof 30
JCO Global Oncology|November 9, 2023
Global Cancer Drug Development-A Report From the 2022 Accelerating Anticancer Agent Development and Validation MeetingBrooke E Wilson, Richard Sullivan, Richard Peto, et al.The Oncologist|July 24, 2024
Patients' considerations of time toxicity when assessing cancer treatments with marginal benefitArjun Gupta, Michael D Brundage, Jacqueline Galica, et al.The Oncologist|September 23, 2023
Breast Cancer-Related Financial Toxicity in Sri Lanka: Insights From a Lower Middle-Income Country With Free Universal Public HealthcareSarith Ranawaka, Sathika Gunarathna, Sanjeeva Gunasekera, et al.JNCI Cancer Spectrum|February 21, 2026
Oncologist perspectives on the time toxicity of palliative systemic treatments for advanced cancerSamuel X Stevens, Isaac Y Addo, Ella El-Katateny, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2017
Setting Quality Improvement Priorities for Women Receiving Systemic Therapy for Early-Stage Breast Cancer by Using Population-Level Administrative DataKatherine A Enright, Nathan Taback, Melanie Lynn Powis, et al.JCO Global Oncology|May 27, 2022
Colorectal Cancer Treatment Characteristics and Concordance With Guidelines in Sri Lanka: Results From a Hospital-Based Cancer RegistryDon Thiwanka Wijeratne, Sanjeeva Gunasekara, Christopher M Booth, et al.Journal of Palliative Care|July 17, 2019
Management of Cancer-Associated Intestinal Obstruction in the Final Year of LifeShaila J Merchant, Susan B Brogly, Christopher M Booth, et al.Journal of Global Oncology|December 16, 2017
Delivery of Global Cancer Care: An International Study of Medical Oncology WorkloadAdam Fundytus, Richard Sullivan, Verna Vanderpuye, et al.JAMA Internal Medicine|October 18, 2021
Real-world Use of and Spending on New Oral Targeted Cancer Drugs in the US, 2011-2018Mengyuan Fu, Huseyin Naci, Christopher M Booth, et al.The Oncologist|May 25, 2023
Contact Days Associated With Cancer Treatments in the CCTG LY.12 TrialArjun Gupta, Annette E Hay, Michael Crump, et al.Pageof 30